Immunoassay device for diagnosing congestive heart failure
(19)AUSTRALIAN PATENT OFFICE(54) Title Immunoassay device for diagnosing congestive heart failure(51)6 International Patent Classification(s) G01N 033/543 (21) Application No: 2003294303 (22) Application Date: 2003 .11.17 (87) WIPO No: WO04/045381(30) Priority Data (31) Number (32) Date 10/299,583 2002.11.18 10/359,047 2003 .02.04 (33) Country USus(43) (43) Publication Date : 2004.06.15 Publication Journal Date : 2004 .07.15(71) Applicant(s) PRINCETON BIOMEDITECH CORPORATION(72) Inventor(s) Kim, Kyung-Ah; Jackowski, George;Choi, Joo Younq; Kang, Jemo(-1-1) Application NoAU2003294303 A8(19)AUSTRALIAN PATENT OFFICE(54) Title Immunoassay device for diagnosing congestive heart failure(51)6 International Patent Classification(s) G01N 033/543 (21) Application No: 2003294303 (22) Application Date: 2003 .11.17 (87) WIPO No: WO04/045381(30) Priority Data (31) Number (32) Date 10/299,583 2002.11.18 10/359,047 2003 .02.04 (33) Country USus(43) (43) Publication Date : 2004.06.15 Publication Journal Date : 2004 .07.15(71) Applicant(s) PRINCETON BIOMEDITECH CORPORATION(72) Inventor(s) Kim, Kyung-Ah; Jackowski, George;Choi, Joo Younq; Kang, Jemo-1- An immunochemical assay device for determining the presence of NT-proBNP alone or conjunctively with Cardiac Troponin I comprising a base member, an array disposed on the base member, and at least one assay indicia zone. The array comprises (i) a reservoir pad to receive sample liquid, (ii) a wicking membrane, and (iii) at least one filter zone interposed between the wicking membrane and the reservoir pad. The filter zone being operable to permit passage of any specific immunocomplex to the wicking membrane while impeding passage of larger components. CLAIMS What is claimed is: Claim 1. In an immunochemical assay device of the type wherein, a base member; at least one array disposed on said base member, said array comprising : (i) a reservoir pad having sufficient porosity and volume to receive and contain a liquid; (ii) a wicking membrane disposed distally to said reservoir pad, said wicking membrane having sufficient porosity and volume to absorb a substantial proportion of the sample received in said reservoir pad;STDC0430 and (iii) at least one first filter zone which is separate and distinct from said reservoir pad and wicking membrane, and interposed between and contiguous with said wicking membrane and said reservoir pad, said first filter zone having impregnated therein one or more labeled immunochemical components capable of binding to or competing with one or more analytes of interest in said sample to form one or more immuno-complexes ;STDC0867 (iv) at least one second filter zone which is separate and distinct from said reservoir pad, said <Desc/Clms Page number 41> wicking membrane and said first filter zone, and contiguous with said wicking membrane, and said first filter zone, said second filter zone having sufficient porosity and volume to receive and containing a liquid sample on which the assay is to be performed; at least one additional immobilized immunochemical component disposed in at least one assay indicia zone of said wicking membrane downstream of said reservoir pad and defining assay indicia, wherein the improvement comprises: incorporation of an immunoassay for determining the presence of NT-proBNP; said NT-proBNP assay including a goat polyclonal antibody specific for amino acids 26-51 of NT-proBNP and a monoclonal antibody specific for amino acids 1-25 of NT- proBNP.
Claim 2. The assay device of claim 1 further including: an immunoassay for determining the presence of Cardiac Troponin I.
Claim 3. The assay device according to claim 1 wherein said assay device comprises competition assay or a sandwich assay. <Desc/Clms Page number 42> Claim 4. The immunochemical assay device of claim 1 wherein said one or more labeled immunochemical components comprises finely particulate carbon black and one or more immunological ligands or ligand binding molecules covalently linked to a linking reagent, said carbon black being pretreated with dextran and said linking reagent being absorbed on the surface of said dextran-treated carbon black, and wherein the linking reagent is fluorescein isothiocyanate.
Claim 5. The assay device of claim 1 wherein said at least one filter pad is pretreated with reagents to enhance the sensitivity of the assay device.
Claim 6. The assay device of claim 5 wherein said reagents are selected from the group consisting of buffers, detergents, and anticoagulants.